These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10389694

  • 21. Abdominal pain and bacterial meningitis in a previously healthy young adult.
    Riedel DJ, Roddy KM, Sajadi MM.
    Clin Infect Dis; 2008 May 01; 46(9):1458, 1479-80. PubMed ID: 18419455
    [No Abstract] [Full Text] [Related]

  • 22. [Parasitic pneumonia and HTLV-1 infection].
    Cadelis G, Ehret N, Da Cunha S, Dranebois S, Saillard E.
    Rev Mal Respir; 2014 Nov 01; 31(9):867-70. PubMed ID: 25433594
    [No Abstract] [Full Text] [Related]

  • 23. Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding.
    Sukeepaisarnjaroen W, Sawanyawisuth K.
    Trop Gastroenterol; 2014 Nov 01; 35(4):260-1. PubMed ID: 26349175
    [No Abstract] [Full Text] [Related]

  • 24. Utility of PCR in Patients with Strongyloides stercoralis and HTLV-1 Coinfection in French Guiana.
    Blaizot R, Simon S, Brottier J, Blanchet D, Brousse P, Boukhari R, Demar M.
    Am J Trop Med Hyg; 2019 Oct 01; 101(4):848-850. PubMed ID: 31436152
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Regulatory T cells and IgE expression in duodenal mucosa of Strongyloides stercoralis and human T lymphotropic virus type 1 co-infected patients.
    Malpica L, White AC, Leguia C, Freundt N, Barros N, Chian C, Antunez EA, Montes M.
    PLoS Negl Trop Dis; 2019 Jun 01; 13(6):e0007415. PubMed ID: 31170141
    [Abstract] [Full Text] [Related]

  • 27. Image of the month: Target the bugs: Strongyloides stercoralis hyperinfection.
    Hokama A, Kishimoto K.
    Clin Med (Lond); 2021 Mar 01; 21(2):e239-e240. PubMed ID: 33762395
    [Abstract] [Full Text] [Related]

  • 28. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R, Joseph AJ, Chacko A.
    Trop Gastroenterol; 2007 Mar 01; 28(4):176-7. PubMed ID: 18416349
    [Abstract] [Full Text] [Related]

  • 29. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
    Satoh M, Kiyuna S, Shiroma Y, Toma H, Kokaze A, Sato Y.
    Clin Exp Immunol; 2003 Sep 01; 133(3):391-6. PubMed ID: 12930366
    [Abstract] [Full Text] [Related]

  • 30. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
    Foucan L, Genevier I, Lamaury I, Strobel M.
    Med Trop (Mars); 1997 Sep 01; 57(3):262-4. PubMed ID: 9513154
    [Abstract] [Full Text] [Related]

  • 31. [Malignant strongyloidiasis and the HTLV-I virus].
    Neisson-Vernant C, Edouard A.
    Rev Prat; 1990 Oct 11; 40(23):2127-8. PubMed ID: 2237217
    [Abstract] [Full Text] [Related]

  • 32. A 56-year-old woman with rash, paralytic ileus, and massive gastrointestinal bleeding.
    Seas C, Legua P.
    Clin Infect Dis; 2009 Oct 01; 49(7):1094-5, 1132-3. PubMed ID: 19739959
    [No Abstract] [Full Text] [Related]

  • 33. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
    Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K.
    Clin Exp Immunol; 2002 Feb 01; 127(2):354-9. PubMed ID: 11876761
    [Abstract] [Full Text] [Related]

  • 34. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
    Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES.
    J Infect Dis; 1994 Mar 01; 169(3):692-6. PubMed ID: 8158055
    [Abstract] [Full Text] [Related]

  • 35. Infiltrating Strongyloides stercoralis presenting as duodenal obstruction.
    Suvarna D, Mehta R, Sadasivan S, Raj VV, Balakrishnan V.
    Indian J Gastroenterol; 2005 Mar 01; 24(4):173-4. PubMed ID: 16204912
    [Abstract] [Full Text] [Related]

  • 36. Biliary obstruction resulting from Strongyloides stercoralis infection. Report of a case.
    Delarocque Astagneau E, Hadengue A, Degott C, Vilgrain V, Erlinger S, Benhamou JP.
    Gut; 1994 May 01; 35(5):705-6. PubMed ID: 8200571
    [Abstract] [Full Text] [Related]

  • 37. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan.
    Sato Y, Shiroma Y, Kiyuna S, Toma H, Kobayashi J.
    Trans R Soc Trop Med Hyg; 1994 May 01; 88(1):59. PubMed ID: 8154005
    [No Abstract] [Full Text] [Related]

  • 38. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
    Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M.
    Trop Med Parasitol; 1992 Sep 01; 43(3):199-200. PubMed ID: 1470843
    [Abstract] [Full Text] [Related]

  • 39. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study.
    Salvador F, Sulleiro E, Piron M, Sánchez-Montalvá A, Sauleda S, Molina I.
    Acta Trop; 2017 Dec 01; 176():412-414. PubMed ID: 28939495
    [Abstract] [Full Text] [Related]

  • 40. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E.
    J Infect Chemother; 2003 Dec 01; 9(4):355-7. PubMed ID: 14691660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.